Other primary gonarthrosis
Conditions
Interventions
This is a two-arm, double-blind, randomized controlled clinical trial. Experimental group: 25 elderly (women and male) with knee osteoarthritis (grades 2 or 3) who will receive a multicomponent therap
Sponsors
Obras Socias e Educacionais de Luz
Universidade Santo Amaro
Eligibility
Age
60 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age between 60 and 80 years; female and masculine gender; diagnosis of Medial Femorotibial Osteoarthritis confirmed by X-ray examination; grade 2 or 3 Knee Osteoarthritis according to the Kellgren and Lawrence criteria
Exclusion criteria
Exclusion criteria: Diagnosis of Osteoarthritis in the Hip and/or Ankle; grade 4 Osteoarthritis in one or both knees; body mass index less than 35 kg/m²; presence of Vestibulocochlear Diseases; uncontrolled Cardiac or Respiratory Arrhythmias; Convulsive Syndrome; Musculoskeletal Disorders with functional limitation, such as Diabetic Neuropathies and Cutaneous Ulcers of any etiology; use of Prostheses or Orthoses in the lower limbs; Fractures in the last six months; presence of Dementia; inability to Walk independently; being under Physical Therapy treatment concurrently with the intervention period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assess pain intensity, determined by the Visual Analog Scale at baseline and end of study. Expect a mean reduction in pain of at least 2 cm.;Assess functionality, as determined by the Lequesne and WOMAC algofunctional questionnaires, at baseline and end of study. A mean reduction of 10% in questionnaire scores is expected. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assess gait performance using the six-minute walk test at baseline and end of the study. An average 10% increase in walking speed is expected.;Assess the risk of falls, as determined by the Falls Risk Awareness Questionnaire-FRAQ-Brazil (FRAQ) at baseline and end of the study. An average increase of 10% in the total score is expected.;Assess physical performance using the Timed Up & Go Test (TUG), Chester Step Test, and Floor Transfer Test at baseline and end of the study. An average 10% increase is expected.;Assess physical activity, as determined by the International Physical Activity Questionnaire (IPAQ), at baseline and end of the study. An average 10% increase in these scores is expected.;Assess foot function, as determined by the Foot Function Index (FFI) questionnaire at baseline and end of the study. An average 10% increase in these scores is expected.;Assess plantar pressure and body sway (balance) determined by the pressure platform at baseline and end of the study. A mean reduction in plantar pressure and sway of 15% is expected.;Assess pain knowledge, as determined by the Neurophysiology of Pain questionnaire, at baseline and end of the study. A mean increase in pain knowledge of 15% is expected.;Assess psycho-emotional factors, determined by the catastrophizing scale, the Tampa scale, and pain perception, at baseline and end of the study. A mean reduction in psycho-emotional factors of 15% is expected.;Assess the overall effect of the intervention, as determined by the acceptability, suitability, feasibility, and patient satisfaction questionnaire at baseline and end of study. An average acceptability of 50% is expected. | — |
Countries
Brazil
Contacts
Public ContactAna Paula Ribeiro
Universidade Santo Amaro
Outcome results
None listed